Castle Biosciences, Inc. Common Stock (CSTL) is a publicly traded Healthcare sector company. As of May 21, 2026, CSTL trades at $20.38 with a market cap of $585.97M and a P/E ratio of -23.44. CSTL moved +4.35% today. Year to date, CSTL is -48.64%; over the trailing twelve months it is +21.39%. Its 52-week range spans $14.59 to $44.28. Analyst consensus is strong buy with an average price target of $44.40. Rallies surfaces CSTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Castle Biosciences, Inc. Common Stock (CSTL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CSTL moved +4.35% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.38 |
| Market Cap | $585.97M |
| P/E Ratio | -23.44 |
| EPS | $-0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $14.59 |
| Volume | 323.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $344.23M |
| Net Income | $-24.16M |
| Gross Margin | 79.37% |
5 analysts cover CSTL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.40.